• Our offerings
    • Market Access Strategy, HTA, and Health Economics
    • Nordic RWE & Evidence Generation
    • AI & Dashboard Solutions
    • Policy Shaping & Life Science Consulting
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Danish quality institute schedules 2026 guideline webinars

Danish Medicines Council appraised 84 new medicines in 2025

Denosumab biosimilars: Danish council urges cheapest choice

Medicinrådet launches real-world data pilots in oncology

Region Midtjylland appoints new member to Medicinrådet

Fresh Publication: Understanding What Drives NICE Recommendations for Medical Devices

MedTech Pricing: Why Value-Based Procurement Still Struggles to Scale

European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

Impact of JCA on Sweden’s HTA system?

Impact of EU JCA on the Nordic HTA and Reimbursement Processes

Previous 1 … 4 5 6 7 8 Next

Leveraging Nordic data & insights to support your Market Access goals.

NHTA Copenhagen
Nelson Mandelas Allé 14, 2450 Copenhagen SV, Denmark

NHTA Stockholm
Vasagatan 10, 5th floor, 111 20 Stockholm, Sweden

Contact us

+45 44 222 777
CVR: 39842882

+46 70-322 66 65
Org.nr: 559438-4207

contact@nhta.com

Navigation

  • Our offerings
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Follow us on LinkedIn

LinkedIn
  • Data Protection Policy
  • Cookie Policy